Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2025 08:00 ET | Source: Biomea Fusion, Inc.

Biomea Fusion to Present Poster Presentations at ObesityWeek®2025

SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present...
October 16, 2025 06:20 ET | Source: Research and Markets

U.S. Semaglutide Market Trends and Investment Strategies 2025-2033: Retail Pharmacies Play Key Role in Distribution Amid Growing Demand

Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "United States Semaglutide Market Report by Product, Application, Distribution Channel, States and Company Analysis, 2025-2033" has been added to ...
September 23, 2025 13:03 ET | Source: Shotsy Co.

UPDATE - Shotsy Names Eric Perakslis as Chief Science Officer to Advance Safe, Science-Backed GLP-1 Support

PORTLAND, Ore., Sept. 23, 2025 (GLOBE NEWSWIRE) -- When it comes to GLP-1 weight loss medications, including Ozempic®, Zepbound® and Wegovy®, having access is only part of the equation. Patients need...
September 23, 2025 08:45 ET | Source: Shotsy Co.

Shotsy Names Eric Perakslis as Chief Science Officer to Advance Safe, Science-Backed GLP-1 Support

PORTLAND, Ore., Sept. 23, 2025 (GLOBE NEWSWIRE) -- When it comes to GLP-1 weight loss medications, including Ozempic®, Zepbound® and Wegovy®, having access is only part of the equation. Patients need...
August 12, 2025 07:00 ET | Source: Actual Veggies

Actual Veggies Named to 2025 Inc. 5000 List of Fastest-Growing Private Companies in America

Denver, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Actual Veggies, a CPG leader known for its chef-crafted veggie burgers and vegetable-forward products, has been named to the 2025 Inc. 5000 list of...
July 14, 2025 06:04 ET | Source: Research and Markets

Europe Glucagon-like Peptide-1 (GLP-1) Agonists Research Report 2025 | Market to Reach $14.34 Billion by 2034, Driven by Innovative R&D, Strategic Collaborations, and Drug Formulation Advancements

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Europe Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering. The...
July 14, 2025 05:56 ET | Source: Research and Markets

GLP-1 Agonists Drug Pipeline Analysis Market Report 2025 | Next-generation GLP-1 Agonists Pave the Way for Diabetes and Obesity Management

Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "GLP-1 Agonists Drug Pipeline Analysis Report 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.The GLP-1 Agonists Drug Pipeline...
July 10, 2025 10:52 ET | Source: Research and Markets

United States Glucagon-like Peptide-1 (GLP-1) Agonists Market Report 2025-2034 | Expanding Clinical Trials and Increasing Insurance Coverage to Boost Growth Prospects

Dublin, July 10, 2025 (GLOBE NEWSWIRE) -- The "United States Glucagon-like Peptide-1 (GLP-1) Agonists Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's...
July 02, 2025 05:43 ET | Source: Research and Markets

Semaglutide Market Forecast Report 2025-2033 | Growth Accelerates Amid Rising Awareness, Regulatory Approvals, and Strong Pipeline Advancements

Dublin, July 02, 2025 (GLOBE NEWSWIRE) -- The "Semaglutide Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's...
June 17, 2025 09:04 ET | Source: PMGC Holdings Inc.

Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases

NorthStrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases